ATE297949T1 - Therapeutische verbindungen gegen eierstockkrebs - Google Patents
Therapeutische verbindungen gegen eierstockkrebsInfo
- Publication number
- ATE297949T1 ATE297949T1 AT01962220T AT01962220T ATE297949T1 AT E297949 T1 ATE297949 T1 AT E297949T1 AT 01962220 T AT01962220 T AT 01962220T AT 01962220 T AT01962220 T AT 01962220T AT E297949 T1 ATE297949 T1 AT E297949T1
- Authority
- AT
- Austria
- Prior art keywords
- ovarian cancer
- therapeutic compounds
- compounds against
- against ovarian
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000012642 immune effector Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22624300P | 2000-08-17 | 2000-08-17 | |
| PCT/US2001/025708 WO2002014352A2 (en) | 2000-08-17 | 2001-08-17 | Therapeutic compounds for ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE297949T1 true ATE297949T1 (de) | 2005-07-15 |
Family
ID=22848127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01962220T ATE297949T1 (de) | 2000-08-17 | 2001-08-17 | Therapeutische verbindungen gegen eierstockkrebs |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20020160959A1 (de) |
| EP (1) | EP1309625B1 (de) |
| JP (1) | JP2004506421A (de) |
| AT (1) | ATE297949T1 (de) |
| AU (1) | AU2001283416A1 (de) |
| CA (1) | CA2417152A1 (de) |
| DE (1) | DE60111538D1 (de) |
| WO (1) | WO2002014352A2 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9901256D0 (en) * | 1999-01-20 | 1999-03-10 | Smithkline Beecham Biolog | Novel compounds |
-
2001
- 2001-08-17 EP EP01962220A patent/EP1309625B1/de not_active Expired - Lifetime
- 2001-08-17 WO PCT/US2001/025708 patent/WO2002014352A2/en not_active Ceased
- 2001-08-17 AU AU2001283416A patent/AU2001283416A1/en not_active Abandoned
- 2001-08-17 US US09/931,969 patent/US20020160959A1/en not_active Abandoned
- 2001-08-17 CA CA002417152A patent/CA2417152A1/en not_active Abandoned
- 2001-08-17 AT AT01962220T patent/ATE297949T1/de not_active IP Right Cessation
- 2001-08-17 JP JP2002519489A patent/JP2004506421A/ja not_active Withdrawn
- 2001-08-17 DE DE60111538T patent/DE60111538D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2417152A1 (en) | 2002-02-21 |
| DE60111538D1 (de) | 2005-07-21 |
| EP1309625A2 (de) | 2003-05-14 |
| AU2001283416A1 (en) | 2002-02-25 |
| WO2002014352A9 (en) | 2004-03-04 |
| EP1309625B1 (de) | 2005-06-15 |
| JP2004506421A (ja) | 2004-03-04 |
| WO2002014352A3 (en) | 2003-01-16 |
| US20020160959A1 (en) | 2002-10-31 |
| WO2002014352A2 (en) | 2002-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI1897548T4 (fi) | T-solujen säätely | |
| MX338940B (es) | Identificacion de epitopos ige novedosos. | |
| IL214325A (en) | Antibody against cmet, a drug that includes and uses it | |
| EA200870130A1 (ru) | Антитела против ил-6, предотвращающие связывание с gp130 комплекса ил-6 и альфа-рецептора ил-6 | |
| EP4461318A3 (de) | Neuartige antikörper-wirkstoff-konjugate gegen prostataspezifisches membranantigen (psma) | |
| CR11399A (es) | ANTICUERPOS ANTI-IL-12/23p40, EPITOPES, FORMULACIONES, COMPOSICIONES, METODOS Y USOS | |
| UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
| TNSN07020A1 (en) | Her2 antibody composition | |
| AU9399501A (en) | Therapeutic antibodies | |
| MX2016007865A (es) | Peptidos citotoxicos y conjugados de los mismos. | |
| CY1115147T1 (el) | Εξουδετερωτικα αντισωματα που εχουν ειδικοτητα για ανθρωπινη il-17 | |
| EP2570137A3 (de) | Antikörper zur Bindung von humaner dendritischer und Epithelzelle 205 (DEC-205) | |
| ATE292640T1 (de) | Therapeutische verbindungen gegen eierstockkrebs | |
| SI1572087T1 (sl) | Protitelesa proti antigenu tmeff2 raka in njihovauporaba | |
| NO20061412L (no) | Terapi av okulaere foretyrrelser | |
| DE60238555D1 (de) | Parathormon-antikörper und damit zusammenhängende verfahren | |
| DE60116068D1 (de) | Therapeutische anti-cytomegalovirus verbindungen | |
| DE602006019977D1 (de) | Therapie mit anti-cd4-antikörpern und bestrahlung | |
| MX2022005718A (es) | Anticuerpos tmem219 y usos terapeuticos de los mismos. | |
| UA94211C2 (ru) | Выделенное полностью человеческое моноклональное cd3 антитело | |
| WO2001068677A3 (en) | Derivatives of breast canacer antigen her-2 for therapeutical use | |
| ATE297949T1 (de) | Therapeutische verbindungen gegen eierstockkrebs | |
| WO2001092307A3 (en) | Therapeutic compounds for ovarian cancer | |
| WO2002012272A8 (en) | Therapeutic anti-melanoma compounds | |
| WO2001070767A3 (en) | Therapeutic anti-melanoma compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |